RWM
TMO icon

Ritholtz Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Ritholtz Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76M Sell
7,503
-946
-11% -$454K 0.06% 251
2026
Q1 		$4.15M Sell
8,449
-793
-9% -$430K 0.07% 199
2025
Q4 		$5.36M Buy
9,242
+2,349
+34% +$1.33M 0.1% 133
2025
Q3 		$3.34M Buy
6,893
+1,809
+36% +$842K 0.07% 213
2025
Q2 		$2.06M Sell
5,084
-44
-0.9% -$18.4K 0.05% 288
2025
Q1 		$2.55M Buy
5,128
+702
+16% +$380K 0.08% 192
2024
Q4 		$2.3M Sell
4,426
-346
-7% -$190K 0.07% 199
2024
Q3 		$2.95M Buy
4,772
+341
+8% +$202K 0.09% 157
2024
Q2 		$2.45M Buy
4,431
+158
+4% +$90.5K 0.08% 163
2024
Q1 		$2.48M Buy
4,273
+365
+9% +$205K 0.09% 157
2023
Q4 		$2.07M Buy
3,908
+254
+7% +$123K 0.08% 163
2023
Q3 		$1.85M Buy
3,654
+1,041
+40% +$555K 0.08% 154
2023
Q2 		$1.36M Sell
2,613
-927
-26% -$500K 0.06% 205
2023
Q1 		$2.04M Buy
3,540
+476
+16% +$268K 0.1% 126
2022
Q4 		$1.69M Sell
3,064
-1,080
-26% -$572K 0.09% 152
2022
Q3 		$2.1M Buy
4,144
+1,344
+48% +$752K 0.11% 129
2022
Q2 		$1.52M Buy
2,800
+423
+18% +$233K 0.1% 131
2022
Q1 		$1.4M Sell
2,377
-1,269
-35% -$729K 0.09% 130
2021
Q4 		$2.43M Buy
3,646
+108
+3% +$67.4K 0.15% 66
2021
Q3 		$2.02M Buy
3,538
+334
+10% +$183K 0.14% 72
2021
Q2 		$1.62M Sell
3,204
-467
-13% -$220K 0.12% 83
2021
Q1 		$1.68M Buy
3,671
+2,355
+179% +$1.12M 0.14% 73
2020
Q4 		$613K Buy
1,316
+124
+10% +$58.1K 0.06% 133
2020
Q3 		$526K Buy
1,192
+340
+40% +$140K 0.06% 126
2020
Q2 		$309K Buy
852
+75
+10% +$25.1K 0.04% 172
2020
Q1 		$220K Sell
777
-29
-4% -$9.14K 0.04% 138
2019
Q4 		$262K Buy
+806
New +$244K 0.04% 120

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ritholtz Wealth Management's TMO Position: Q2 2026 in Review

Ritholtz Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $454K and leaving 7,503 shares worth $3.76M. The position accounts for 0.06% of the portfolio, ranked #251.

Ritholtz Wealth Management first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.36M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ritholtz Wealth Management held 7,503 shares of Thermo Fisher Scientific worth $3.76M as of Q2 2026.
  • Ritholtz Wealth Management sold 946 Thermo Fisher Scientific shares in Q2 2026, an estimated $454K.
  • Thermo Fisher Scientific made up 0.06% of Ritholtz Wealth Management's portfolio in Q2 2026, its #251 holding.
  • Ritholtz Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Ritholtz Wealth Management's Thermo Fisher Scientific position peaked at $5.36M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.